Get started
Author

Jonas Alex Morales Saute

Observed names: J SAUTE, J. A. M. Saute, J. A. Saute, J. Saute, J.A. Saute, J.A.M. Saute, JAM Saute, Jonas A Morales Saute, Jonas A. M. Saute, Jonas A. Morales Saute, Jonas A. Saute, Jonas A.M. Saute, Jonas Alex M. Saute, Jonas Alex Morales SAUTE, Jonas Alex Saute, Jonas Saute, Morales Saute, Jonas Alex, SAUTE, Jonas Alex Morales, Saute, Jonas Alex M., Saute, Jonas Alex Morales
Observed institutions: Universidade Federal de Minas Gerais, Universidade Federal do Rio Grande do Sul, Gunma University, Universidade de São Paulo, Massachusetts General Hospital, Hospital de Clínicas de Porto Alegre, Hospital das Clínicas da Universidade Federal de Minas Gerais, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Segawa Neurological Clinic for Children, Tokushima University
ORCID: 0000-0003-1141-6573
Observed ORCIDs: 0000-0003-1141-6573, 0000-0003-1646-2667
OpenAlex ID: A5089200023
D NAJC 6 M utations A ssociated W ith E arly‐ O nset P arkinson's D isease
2015 · Simone Olgiati, Marialuisa Quadri, et al. · Annals of Neurology · 197
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis
2021 · Payam Mohassel, Sandra Donkervoort, et al. · Nature Medicine · 149
Ataxia Rating Scales—Psychometric Profiles, Natural History and Their Application in Clinical Trials
2011 · On behalf of the Iberoamerican Multidisciplinary Network for the Study of Movement Disorders (RIBERMOV) Study Group, Jonas Alex Morales Saute, et al. · The Cerebellum · 130
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial
2017 · Ludger Schöls, Tim W Rattay, et al. · Brain · 111
PDF
Interleukin-6 Serum Levels in Patients with Parkinson’s Disease
2009 · Kerly Wollmeister Hofmann, Artur Francisco Schumacher Schuh, et al. · Neurochemical Research · 99
Nonmotor and extracerebellar features in Machado‐Joseph disease: A review
2013 · José Luiz Pedroso, Marcondes C. França, et al. · Movement Disorders · 98
A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease
2018 · Filippo Pinto e Vairo, Bruna Cristine Chwal, et al. · Molecular Genetics and Metabolism · 97
Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations
2020 · Santiago Perez‐Lloret, Bart van de Warrenburg, et al. · Movement Disorders · 92
PDF
Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´s disease
2009 · Eliseu Felippe dos Santos, Estela Natacha Brandt Busanello, et al. · Metabolic Brain Disease · 76
A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)
2008 · C. Kieling, C. R. M. Rieder, et al. · European Journal of Neurology · 74
A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease
2014 · Jonas Alex Morales Saute, Raphael Machado de Castilhos, et al. · Movement Disorders · 72
Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
2017 · Adriano M. de Assis, Jonas Alex Morales Saute, et al. · Frontiers in Neurology · 67
PDF
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
2022 · Museer A. Lone, Mari J. Aaltonen, et al. · Journal of Clinical Investigation · 61
PDF
MR Imaging in Spinocerebellar Ataxias: A Systematic Review
2016 · A. Klaes, E. Reckziegel, et al. · American Journal of Neuroradiology · 57
PDF
Progression Rate of Neurological Deficits in a 10-Year Cohort of SCA3 Patients
2010 · Laura Bannach Jardim, Lisiane Hauser, et al. · The Cerebellum · 57
Clinicogenetic lessons from 370 patients with autosomal recessive limb‐girdle muscular dystrophy
2019 · Pablo B. Winckler, André M.S. da Silva, et al. · Clinical Genetics · 56
Cerebrotendinous Xanthomatosis: A practice review of pathophysiology, diagnosis, and treatment
2022 · Paulo Ribeiro Nóbrega, Anderson Moura Bernardes, et al. · Frontiers in Neurology · 55
PDF
Machado Joseph disease: clinical and genetic aspects, and current treatment
2015 · Jonas Alex Morales Saute, Laura Bannach Jardim · Expert Opinion on Orphan Drugs · 53
Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN)
2022 · Têmis Maria Félix, Bibiana Mello de Oliveira, et al. · Orphanet Journal of Rare Diseases · 49
PDF
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy
2020 · Rodrigo de Holanda Mendonça, Ciro Matsui, et al. · Neurology Genetics · 49
PDF
Clinical and molecular characterization of hereditary spastic paraplegias: A next-generation sequencing panel approach
2017 · Daniela Burguez, Márcia Polese-Bonatto, et al. · Journal of the Neurological Sciences · 47
Body Mass Index is Inversely Correlated with the Expanded CAG Repeat Length in SCA3/MJD Patients
2011 · Jonas Alex Morales Saute, Andrew Chaves Feitosa da Silva, et al. · The Cerebellum · 46
Effects of Depressive-Like Behavior of Rats on Brain Glutamate Uptake
2010 · Roberto Farina Almeida, Ana Paula Thomazi, et al. · Neurochemical Research · 46
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS
2017 · Roberto Giugliani, Filippo Vairo, et al. · The Lancet Child & Adolescent Health · 44
Clinical and molecular findings in a cohort of ANO5‐related myopathy
2019 · André M. S. Silva, Antônio R. Coimbra-Neto, et al. · Annals of Clinical and Translational Neurology · 42
PDF
Works count: 245
Citation count: 3,094
H-index: 35
I10-index: 64
Year
Topic
Type